Home Jialiang Medical's Three Innovative Neurosurgical Devices Receive NMPA Approval via Fast-Track Review

Jialiang Medical's Three Innovative Neurosurgical Devices Receive NMPA Approval via Fast-Track Review

Oct 29, 2025 11:30 CST Updated 11:30
GenLight

Innovative Medical Device Solution Provider

NMPAAnnouncement of ApprovalGenlight Neurotech's Three Innovative Products Launched: MRI-Guided Semiconductor Laser Therapy Device, Single-Use Laser Fiber Optic Kit, and Stereotactic Surgical Planning Software
Image

Product Composition

The magnetic resonance monitored semiconductor laser treatment device consists of a main unit and accessories.

The disposable laser fiber kit consists of a medical fiber optic catheter assembly and cooling water tubing.

The stereotactic surgical planning software consists of an installation USB drive and a key.

Intended Use of the Product

The magnetic resonance-guided semiconductor laser therapy system, used in conjunction with a single-use laser fiber kit, is intended for laser ablation of localized lesions in patients with drug-resistant epilepsy (focal seizures with a well-defined epileptogenic zone or a clear epileptic pathway). The stereotactic surgical planning software, used in combination with the magnetic resonance-guided semiconductor laser therapy system, is applied for creating head stereotactic surgical plans.

Three products from Genlight Neurotech can minimize surgical pathway damage to normal brain tissue and better preserve cognitive function.

Company Introduction
HangzhouGenlight Neurotech was established in 2020.In HangzhouFuture Sci-Tech City is a high-tech platform enterprise focusing on the industrialization of cutting-edge technologies in the fields of brain science and neurosurgery.Industry. The company has built an advancedThree major technology platforms: Brain-Computer Modulation, Medical Lasers, and Brain-Computer Chips, providing innovative device solutions for a variety of neurological disorders.